Key Record Dates
ClinicalTrials.gov Identifier: | NCT03581292 |
---|---|
Brief Title: | Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations |
First Submitted : | July 4, 2018 |
First Submitted that Met QC Criteria : | July 4, 2018 |
First Posted : | July 10, 2018 |
Results First Submitted : | February 22, 2024 |
Results First Posted with QC Comments : | March 19, 2024 |
Results First Submitted that Met QC Criteria : | March 28, 2024 |
Results First Posted : | April 23, 2024 |
Last Update Submitted that Met QC Criteria : | May 16, 2024 |
Last Update Posted : | May 20, 2024 (Estimate) |